FLGT NASDAQ
Fulgent Genetics, Inc.
1W: +7.3%
1M: +6.7%
3M: -25.0%
YTD: -32.1%
1Y: -18.1%
3Y: -51.8%
5Y: -75.3%
$17.11
-0.27 (-1.55%)
Weekly Expected Move ±7.2%
$13
$15
$16
$17
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (42)
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Fulgent Genetics, Inc. Q1 2026 Earnings Call Summary
Fulgent (FLGT) Q1 2026 Earnings Transcript
Fulgent outlines $350M 2026 revenue outlook following Bako/StrataDx acquisition
Full Transcript: Fulgent Genetics Q1 2026 Earnings Call
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
Earnings Scheduled For May 1, 2026
[10-Q] Fulgent Genetics, Inc. Quarterly Earnings Report - Stock Titan
Fulgent Genetics Non-GAAP EPS of -$0.36 misses by $0.01, revenue of $71.1M beats by $3.01M
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
Here are the major earnings before the open Friday
Fulgent Genetics Q1 2026 Earnings Preview
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of “Hold” by Analysts
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
Fulgent Genetics, Inc. (NASDAQ:FLGT) Sees Large Increase in Short Interest
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Rating of “Hold” from Brokerages
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Catalyst Watch: Eyes on oil prices, inflation reads, and Oracle earnings
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of “Hold” by Brokerages
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript
Fulgent Genetics Non-GAAP EPS of $0.16 beats by $0.13, revenue of $83.3M misses by $2.08M
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
Here are the major earnings before the open Friday
Fulgent Genetics Q4 2025 Earnings Preview
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Fulgent Genetics (NASDAQ:FLGT) & PPJ Enterprise (OTCMKTS:PPJE) Head to Head Survey
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock
SG Americas Securities LLC Purchases New Position in Fulgent Genetics, Inc. $FLGT
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts
Contrasting Bullfrog AI (NASDAQ:BFRG) & Fulgent Genetics (NASDAQ:FLGT)
Analyzing Careview Communications (OTCMKTS:CRVW) & Fulgent Genetics (NASDAQ:FLGT)
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Financial Contrast: Patient Portal Technologies (OTCMKTS:PPRG) versus Fulgent Genetics (NASDAQ:FLGT)